387 related articles for article (PubMed ID: 3112225)
1. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
2. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
Defrance T; Aubry JP; Vanbervliet B; Banchereau J
J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
5. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
6. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
7. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
8. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
Jelinek DF; Lipsky PE
J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
[TBL] [Abstract][Full Text] [Related]
9. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
Ennist DL; Elkins KL; Cheng SC; Howard M
J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
[TBL] [Abstract][Full Text] [Related]
10. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
[TBL] [Abstract][Full Text] [Related]
12. Signal requirements for growth and differentiation of activated murine B lymphocytes.
Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
14. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors.
Tadmori W; Lee HK; Clark SC; Choi YS
J Immunol; 1989 Feb; 142(3):826-32. PubMed ID: 2783602
[TBL] [Abstract][Full Text] [Related]
15. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
17. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
19. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
[TBL] [Abstract][Full Text] [Related]
20. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
Kehrl JH; Muraguchi A; Fauci AS
Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
